TFX:NYE-Teleflex Incorporated (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 235.22

Change

-1.22 (-0.52)%

Market Cap

USD 11.21B

Volume

0.44M

Analyst Target

USD 426.10
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

-0.90 (-0.38%)

USD 68.65B
ALC Alcon AG

-1.24 (-1.31%)

USD 46.87B
RMD ResMed Inc

-1.38 (-0.56%)

USD 37.59B
BAX Baxter International Inc

-0.13 (-0.36%)

USD 18.36B
AVTR Avantor Inc

-0.06 (-0.27%)

USD 15.33B
ATR AptarGroup Inc

+0.33 (+0.20%)

USD 11.25B
BLCO Bausch + Lomb Corp

-0.32 (-1.54%)

USD 7.32B
STVN Stevanato Group SpA

+0.08 (+0.43%)

USD 4.94B
WRBY Warby Parker Inc

+0.20 (+1.18%)

USD 2.09B
INFU InfuSystems Holdings Inc

-0.19 (-3.01%)

USD 0.15B

ETFs Containing TFX

QRH:CA 0.00 % 1.20 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.66% 53% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.66% 53% F 34% F
Trailing 12 Months  
Capital Gain 25.44% 68% D+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.44% 68% D+ 66% D+
Trailing 5 Years  
Capital Gain -32.02% 44% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -32.02% 50% F 29% F
Average Annual (5 Year Horizon)  
Capital Gain -8.50% 16% F 8% B-
Dividend Return -8.06% 16% F 7% C-
Total Return 0.43% 33% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 19.33% 79% B- 55% F
Risk Adjusted Return -41.73% 11% F 6% D-
Market Capitalization 11.21B 57% F 87% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector